Jsf Financial, LLC Amgen Inc Transaction History

Jsf Financial, LLC

$343 Million
Q4 2024

A detailed history of Jsf Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jsf Financial, LLC holds 2,593 shares of AMGN stock, worth $807,849. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,593

Previous 1,092 137.45%

Holding current value

$807,849

Previous $351,000 92.31%

% of portfolio

0.2%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$258.78 - $328.31 $388,428 - $492,793	1,501 Added 137.45%	2,593 $675,000
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $5,259 - $5,735	-17 Reduced 1.53%	1,092 $351,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $576,210 - $700,246	-2,193 Reduced 66.41%	1,109 $346,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $96,255 - $116,192	358 Added 12.16%	3,302 $938,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2,301 - $2,596	9 Added 0.31%	2,944 $847,000
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $422,431 - $524,460	1,932 Added 192.62%	2,935 $788,000
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $3,428 - $4,053	-16 Reduced 1.57%	1,003 $222,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $4,290 - $5,228	19 Added 1.9%	1,019 $246,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $519,898 - $660,592	-2,270 Reduced 69.42%	1,000 $262,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $36,138 - $40,757	161 Added 5.18%	3,270 $737,000
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $502,947 - $559,693	2,180 Added 234.66%	3,109 $757,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $203,701 - $225,347	929 New	929 $225,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $177,669 - $208,161	-837 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $52,088 - $57,788	-223 Reduced 21.04%	837 $204,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $7,988 - $9,309	36 Added 3.52%	1,060 $264,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $12,333 - $14,687	57 Added 5.89%	1,024 $235,000
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $191,282 - $234,729	967 New	967 $228,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $168,025 - $222,847	-922 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $174,451 - $224,230	922 New	922 $222,000
Q1 2019 Feb 27, 2020	SELL	$180.87 - $203.88 $188,828 - $212,850	-1,044 Closed	0 $0
Q4 2018 Feb 27, 2020	BUY	$178.4 - $208.25 $186,249 - $217,413	1,044 New	1,044 $203,000

Others Institutions Holding AMGN

# of Institutions

3,187

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jsf Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jsf Financial, LLC with notifications on news.

Account

Jsf Financial, LLC Amgen Inc Transaction History